News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Engineering A More Efficient Way To Diagnose Prostate Cancer, University of Michigan Health System Study


2/25/2014 7:09:48 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Computational models enable doctors to assess biomarkers more quickly and cheaply. To diagnose prostate cancer, urologists, such as John Wei, and pathologists, such as Scott Tomlins, at the University of Michigan Health System, use biomarkers, which are biochemical signatures in blood, urine and tissue that suggest the disease may be present. Some biomarkers are genetic. With support from the National Science Foundation (NSF), University of Michigan engineer Brian Denton is working with a multidisciplinary team that includes Wei and Tomlins to develop a quicker and less expensive way to evaluate biomarkers, using computational models. The researchers sift through vast medical databases and then use Denton’s engineering methods to assess the most effective predictors of prostate cancer.

Hey, check out all the engineering jobs. Post your resume today!

Read at ScienceBlog


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES